Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY
Abstract
Authors
M. Saylan V. Beykoz A. Keskinaslan